Keweenaw Land Association Ltd
OTC:KEWL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Keweenaw Land Association Ltd
OTC:KEWL
|
US |
|
B
|
Balurghat Technologies Ltd
BSE:520127
|
IN |
|
Hiap Tong Corporation Ltd
SGX:5PO
|
SG |
|
C
|
Corline Biomedical AB
STO:CLBIO
|
SE |
|
M
|
MIXUE Group
HKEX:2097
|
CN |
Balance Sheet
Balance Sheet Decomposition
Keweenaw Land Association Ltd
Keweenaw Land Association Ltd
Balance Sheet
Keweenaw Land Association Ltd
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
3
|
3
|
2
|
1
|
42
|
10
|
8
|
4
|
|
| Cash Equivalents |
3
|
3
|
2
|
1
|
42
|
10
|
8
|
4
|
|
| Short-Term Investments |
3
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
1
|
1
|
1
|
2
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
1
|
1
|
1
|
2
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
11
|
0
|
0
|
0
|
|
| Total Current Assets |
7
|
6
|
4
|
4
|
53
|
10
|
9
|
4
|
|
| PP&E Net |
34
|
33
|
28
|
28
|
5
|
6
|
7
|
8
|
|
| PP&E Gross |
34
|
33
|
28
|
28
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
1
|
2
|
9
|
9
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
41
N/A
|
40
-2%
|
33
-18%
|
32
-2%
|
58
+82%
|
16
-73%
|
16
+1%
|
15
-6%
|
|
| Liabilities | |||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accrued Liabilities |
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
40
|
0
|
0
|
0
|
|
| Total Current Liabilities |
1
|
1
|
1
|
4
|
40
|
0
|
0
|
0
|
|
| Long-Term Debt |
18
|
19
|
10
|
4
|
0
|
0
|
0
|
0
|
|
| Deferred Income Tax |
1
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
20
N/A
|
20
-2%
|
11
-44%
|
8
-29%
|
40
+408%
|
0
-99%
|
0
+3%
|
0
+20%
|
|
| Equity | |||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
19
|
19
|
21
|
24
|
18
|
15
|
15
|
14
|
|
| Other Equity |
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
21
N/A
|
20
-2%
|
22
+7%
|
24
+12%
|
18
-24%
|
15
-17%
|
15
+1%
|
14
-7%
|
|
| Total Liabilities & Equity |
41
N/A
|
40
-2%
|
33
-18%
|
32
-2%
|
58
+82%
|
16
-73%
|
16
+1%
|
15
-6%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|